Drugs and medical devices must gain approval from the U.S. Food & Drug Administration (FDA) to be sold in the U.S. However, approval does not guarantee a drug or medical device is safe. In fact, a defect in the product, incomplete labeling, or insufficient warnings can cause physical, psychological, or emotional injury. The manufacturer, not the FDA, is responsible for ensuring that its label is updated to protect the public safety.
Weitz & Luxenberg is committed to holding drug and device makers and marketers accountable for the harm they cause. For 30 years, we have strived to help innocent victims harmed by defective drugs and defective medical devices obtain the justice that they deserve.
”You and your staff are to be commended. I have never been involved in a litigation before and had no idea what would happen. You relieved that tension"
Clara S.'s story
Weitz & Luxenberg helped win a $9 billion jury verdict that included, at the time, the seventh-largest determination of punitive damages awarded in the U.S.*
Our firm played key roles in negotiating separate $2.5 billion and $1 billion settlements for our clients and those of other firms who had been implanted with certain types of defective hip implants.
A nationally recognized personal injury law firm, we have nearly 500 dedicated lawyers, paralegals, and support professionals.
Weitz & Luxenberg has over 100 attorneys ready to fight for you, many of whom have decades of experience, and all are at Weitz & Luxenberg because they care about the clients we represent.
Meet More AttorneysFor a free consultation and more information about your legal options, please contact us today.
A surgical procedure that’s gone wrong; prolonged pain and weakness; an inability to return to work or resume your normal activities — these are all potential complications, among many others, that can occur as a result of dangerous drugs or medical devices. Such defective medical products can have a negative impact on your life and the lives of your loved ones. In many cases, the injuries caused by certain drugs or devices are more debilitating than the condition that first led to their use. Fortunately, injured consumers can obtain exceptional representation with Weitz & Luxenberg.
The FDA defines the term “drug” as a substance:
The FDA defines the term “device” as an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory:
No law firm can restore anyone’s life or health, but Weitz & Luxenberg can help seek compensation through exceptional legal representation for harm caused by drugs and devices, including but not limited to:
Some hip implants have inherent problems with their design, which can lead to high failure rates, metallosis, infection, dislocation, or immobility.
Learn more about the connection between weight loss drugs and vision loss. If you used these semaglutides and were diagnosed with NAION, you may be eligible for compensation.
Using chemical hair straightening products can lead to ovarian and uterine cancer. These products can contain hazardous chemicals. Black and Latina women are particularly at risk.
A nationally recognized personal injury and mass tort law firm, Weitz & Luxenberg has won $19 billion in settlements and verdicts.*
for a client who developed bladder cancer after taking Actos*
on behalf of patients whose DePuy ASR hip implants failed and were removed
for patients injured by Stryker Corp.'s Rejuvenate and ABGII modular hip implants
You may be entitled to legal compensation. We would be honored to represent you.
We have locations across the country to conveniently serve our clients.
If you or a family member feel that they may have been affected by Mesothelioma,
feel free to contact us, so that we can fight for you.
* Past performance is no guarantee of future results. The Actos verdict was reduced to approximately $38 million by the trial court on October 27, 2014. The settlements in which Weitz& Luxenberg played leadership roles included patients not represented by Weitz & Luxenberg.
